share_log

RENNOVA HEALTH, INC. COMPLETES REVERSE STOCK SPLIT

RENNOVA HEALTH, INC. COMPLETES REVERSE STOCK SPLIT

RENNOVA健康公司完成反向股票拆分
GlobeNewswire ·  2022/03/16 10:56

WEST PALM BEACH, Fla., March 16, 2022 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVAD), today announced that effective at 5:00 pm, Eastern Time, on March 15, 2022 (the "Effective Time"), the Company completed a 1 for 10,000 reverse stock split of its outstanding common stock. The Company's common stock will open for trading on Wednesday March 16, 2022, on a post-split basis and trade under the symbol RNVAD for 20 days.

佛羅裏達州西棕櫚灘,2022年3月16日(環球通訊社)--Rennova HealtH,Inc.(場外交易代碼:RNVAD),今天宣佈,自美國東部時間2022年3月15日下午5點(“生效時間”)起,公司完成了對其已發行普通股的1比10,000股反向拆分。該公司的普通股將於2022年3月16日星期三在拆分後的基礎上開始交易,交易代碼為RNVAD,為期20天。

As a result of the reverse stock split, every 10,000 shares of the Company's common stock issued and outstanding on the Effective Time will be consolidated into one issued and outstanding share, except to the extent that the reverse stock split results in any of the Company's stockholders owning a fractional share, which fractional share will be in that case paid in cash. In connection with the reverse stock split, there will be no change in the nominal par value per share of $0.0001.

作為反向股票拆分的結果,在有效時間發行和發行的每10,000股公司普通股將合併為一股已發行和流通股,除非反向股票拆分導致公司的任何股東擁有零碎股份,在這種情況下,零碎股份將以現金支付。關於反向股票拆分,每股面值0.0001美元不會發生變化。

Based on the number of shares outstanding on March 9, 2022, the reverse stock split will reduce the number of shares of the Company's common stock outstanding from approximately 44 billion pre-reverse split shares to approximately 4.4 million post-reverse split.

根據2022年3月9日的流通股數量,反向拆分將使公司普通股的流通股數量從反向拆分前的約440億股減少到反向拆分後的約440萬股。

All outstanding preferred shares, stock options, warrants, and equity incentive plans immediately prior to the reverse stock split generally will be appropriately adjusted by dividing the number of shares of common stock into which the preferred shares, stock options, warrants and equity incentive plans are exercisable or convertible by 10,000 and multiplying the exercise or conversion price by 10,000, as a result of the reverse stock split.

由於反向股票拆分,所有緊接反向股票拆分之前的已發行優先股、股票期權、認股權證和股權激勵計劃一般將適當調整,方法是將優先股、股票期權、認股權證和股權激勵計劃可行使或可轉換的普通股股數除以10,000,並將行使或轉換價格乘以10,000。

The Company has retained its transfer agent, Computershare, Inc., to act as its exchange agent for the reverse stock split. As necessary, Computershare will provide stockholders of record as of the Effective Time a letter of transmittal providing instructions for the exchange of their stock certificates. Stockholders owning shares via a broker or other nominee will have their positions automatically adjusted to reflect the reverse stock split, subject to brokers' particular processes, and will not be required to take any action in connection with the reverse stock split.

該公司保留了其轉讓代理公司ComputerShare,Inc.作為其反向股票拆分的交易所代理。如有必要,ComputerShare將向自生效時間起登記在冊的股東提供一份關於交換其股票證書的指示的傳送函。通過經紀人或其他被提名人持有股份的股東將根據經紀人的特定程序自動調整他們的頭寸,以反映反向股票拆分,並且不需要採取任何與反向股票拆分相關的行動。

The reverse stock split was approved by the directors of the Company on March 9, 2022, pursuant to a resolution adopted by written consent of the holders of the majority of the total voting power of the Company's securities on December 15, 2021.

根據2021年12月15日持有公司證券總投票權的多數股東的書面同意通過的決議,公司董事於2022年3月9日批准了反向股票拆分。

About Rennova Health, Inc.
Rennova is a provider of health care services to rural communities. The Company owns one operating acute care hospital in Oneida, Tennessee known as Big South Fork Medical Center (classified as a critical access hospital), an acute care hospital and physician's office located in Jamestown, Tennessee that it plans to reopen and operate, and a rural clinic in Kentucky. For more information, please visit 

Rennova Health公司簡介
Rennova是一家為農村社區提供醫療保健服務的公司。該公司在田納西州奧奈達擁有一家運營中的急性護理醫院,被稱為大南福克醫療中心(被歸類為危重醫院),位於田納西州詹姆斯敦的一家急性護理醫院和醫生辦公室計劃重新開放和運營,以及肯塔基州的一家鄉村診所。欲瞭解更多信息,請訪問

Forward-Looking Statements

前瞻性陳述

This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company's most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.

本新聞稿包括1995年美國私人證券訴訟改革法中安全港條款所指的“前瞻性陳述”。實際結果可能與預期不同,因此,您不應依賴這些前瞻性陳述作為對未來事件的預測。諸如“預期”、“估計”、“項目”、“預算”、“預測”、“預期”、“打算”、“計劃”、“可能”、“將會”、“可能”、“應該”、“相信”、“預測”、“潛在”、“繼續”等詞語以及類似的表述旨在識別此類前瞻性陳述。這些前瞻性陳述涉及重大風險和不確定因素,可能導致實際結果與預期結果大相徑庭。有關這些和其他風險因素的更多信息包含在該公司最近提交給證券交易委員會的文件中。該公司告誡讀者不要過度依賴任何前瞻性陳述,這些陳述僅反映了所作日期的情況。公司不承擔也不接受任何義務或承諾公開發布對任何前瞻性陳述的任何更新或修訂,以反映他們預期的任何變化,或任何此類陳述所基於的事件、條件或情況的任何變化,除非法律要求。

Contact:

聯繫人:

Rennova Health
561-855-1626
info@rennovahealth.com

雷諾瓦健康
561-855-1626
郵箱:Info@rennovaHealth.com


声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論